Latest News

26.06.2019

Genfit in $228m deal with Terns Pharmaceuticals

Genfit SA has licenced the Greater China commercialisation rights for its NASH drug elafibranor  to Terns...

MORE

25.06.2019

Vesalius Biocapital III Fund closes at €120 million

Life sciences venture capitalist Vesalius Biocapital III has announced the final close of the VBC III fund at...

MORE

25.06.2019

Erytech Pharma SA bags US$57m from SQZ Biotechnologies

Erytech Pharma has inked a deal with SQZ Biotechnologies Inc. to develop new immune modulating therapies.

MORE

24.06.2019

Sanofi/Regeneron's IL-33 blocker meets endpoint in POC study

Sanofi‘s and Regeneron‘s IL-33 blocker REGN3500 met primary Phase II endpoint in asthma patients.

MORE

21.06.2019

Karo Pharma acquires Trimb AB

Karo Pharma AB announced it will acquire Trimb Holding AB for MSEK3,400 (€319.6m) and intends to carry out a...

MORE

19.06.2019

UK biotech to make proteins from carbon dioxide emissions

Deep Branch Biotechnology Ltd. from Nottingham has started a feasibility study with the British energy...

MORE